全文获取类型
收费全文 | 21166篇 |
免费 | 1393篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 179篇 |
儿科学 | 536篇 |
妇产科学 | 381篇 |
基础医学 | 2532篇 |
口腔科学 | 784篇 |
临床医学 | 1876篇 |
内科学 | 4481篇 |
皮肤病学 | 497篇 |
神经病学 | 1249篇 |
特种医学 | 542篇 |
外国民族医学 | 5篇 |
外科学 | 2949篇 |
综合类 | 627篇 |
一般理论 | 16篇 |
预防医学 | 1787篇 |
眼科学 | 798篇 |
药学 | 2025篇 |
中国医学 | 233篇 |
肿瘤学 | 1199篇 |
出版年
2024年 | 22篇 |
2023年 | 243篇 |
2022年 | 237篇 |
2021年 | 1155篇 |
2020年 | 767篇 |
2019年 | 940篇 |
2018年 | 1128篇 |
2017年 | 783篇 |
2016年 | 855篇 |
2015年 | 858篇 |
2014年 | 1160篇 |
2013年 | 1351篇 |
2012年 | 1875篇 |
2011年 | 1896篇 |
2010年 | 1111篇 |
2009年 | 869篇 |
2008年 | 1285篇 |
2007年 | 1167篇 |
2006年 | 1015篇 |
2005年 | 853篇 |
2004年 | 672篇 |
2003年 | 582篇 |
2002年 | 481篇 |
2001年 | 120篇 |
2000年 | 133篇 |
1999年 | 114篇 |
1998年 | 66篇 |
1997年 | 61篇 |
1996年 | 59篇 |
1995年 | 51篇 |
1994年 | 30篇 |
1993年 | 48篇 |
1992年 | 75篇 |
1991年 | 53篇 |
1990年 | 45篇 |
1989年 | 71篇 |
1988年 | 41篇 |
1987年 | 32篇 |
1986年 | 43篇 |
1985年 | 32篇 |
1984年 | 39篇 |
1983年 | 39篇 |
1982年 | 19篇 |
1981年 | 23篇 |
1980年 | 18篇 |
1979年 | 21篇 |
1978年 | 20篇 |
1976年 | 19篇 |
1974年 | 16篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
1.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
2.
3.
4.
Aaron Pitzele Mohammad Rahimi Eric Armbrecht 《The journal of maternal-fetal & neonatal medicine》2015,28(15):1770-1773
Objective: To determine whether packed red blood cell (PRBC) transfusion affects post-prandial superior mesenteric artery blood flow velocities (SMA BFVs) in very-low birth weight (VLBW) neonates and if so, at what time point after transfusion restoration of previous SMA BFV patterns occurs.Design/Methods: VLBW pre-term neonates, older than 14 days and tolerating bolus enteral feedings administered every 3?h were enrolled in this prospective observational study. Pulsed Doppler ultrasound was used to measure pre- and post-prandial (at 45?min) time-averaged mean, peak and end diastolic velocities (TAMV, PSV, EDV) immediately before and after 15?ml/kg of PRBC transfusion was given over 3?h; patent ductus arteriosus (PDA) status was also evaluated. Subsequent pre- and post-prandial SMA BFVs were recorded 24 and 48?h after the transfusion.Results: Pre- and post-prandial measurements were obtained for 21 out of 25 enrolled infants. Post-prandial SMA BFVs were attenuated during the feedings immediately after transfusion; at 24 and 48?h after transfusion, changes in post-prandial SMA BFVs were similar to those measured prior to transfusion; the presence of the PDA did not affect results.Conclusions: PRBC transfusion blunted SMA BFV responses to feedings immediately after the transfusion with normalization observed 24?h post-transfusion. 相似文献
5.
6.
Ahmed M. Abu El-Asrar Ajmal Ahmad Eef Allegaert Mohammad Mairaj Siddiquei Priscilla W. Gikandi Gert De Hertogh 《Ocular immunology and inflammation》2020,28(4):575-588
ABSTRACT
Purpose
To investigate the expression of IL-11 and its receptor IL-11Rα and to quantify density of CD163+ M2 macrophages in proliferative diabetic retinopathy (PDR). 相似文献7.
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver‐related morbidity; its prevalence is elevating due to the rising epidemic of obesity. Several clinical trials have examined the effects of curcumin supplementation on anthropometric variables in NAFLD patients with inconclusive results. This dose–response meta‐analysis aimed to evaluate the impact of curcumin supplementation on body mass index (BMI), body weight, and waist circumference (WC) in patients with NAFLD. A systematic review of the literature was conducted using PubMed/Medline, ISI Web of Science, Scopus, Cochrane Library, EMBASE, Google Scholar, Sid.ir, and Magiran.com to identify eligible studies up to March 2019. A meta‐analysis of eligible studies was performed using the random‐effects model to estimate the pooled effect size. Eight randomized controlled trials with 520 participants (curcumin group = 265 and placebo group = 255) were included. Supplementation dose and duration ranged from 70 to 3,000 mg/day and 8 to 12 weeks, respectively. Curcumin supplementation significantly reduced BMI (weighted mean difference [WMD] = ?0.34 kg/m2, 95% CI [?0.64, ?0.04], p < .05) and WC (WMD = ?2.12 cm, 95% CI [?3.26, ?0.98], p < .001). However, no significant effects of curcumin supplementation on body weight were found. These results suggest that curcumin supplementation might have a positive effect on visceral fat and abdominal obesity that have been associated with NAFLD. 相似文献
8.
9.
10.